Table 2 Mean and (SD) of the different indices of the PERSEPP HRQoL questionnaire for all patients before (Pre 1 and Pre 2) and after (Post 1 and Post 2) fampridine
From: Fampridine and quality of life in individuals with multiple sclerosis
PERSEPP (%) (items) | All patients (n = 50) | |||
|---|---|---|---|---|
Pre 1 | Pre 2 | Post 1 | Post 2 | |
Overall (33) | 62.4 (16.4) | 62.5 (16.9) | 66.3 (17.6) | 68.9 (18.4)* |
Social support (5) | 87.2 (14.2) | 86.5 (16.4) | 87.5 (16.7) | 88.2 (17) |
Relationship dif. (9) | 52.2 (22.8) | 54.7 (24.1) | 59 (24.5) | 61.9 (23.2)** |
Fatigue (4) | 43.5 (30.9) | 44 (29.2) | 52.4 (32.8)*** | 52.8 (34.7)*** |
State of mind and sleep disorder (7) | 63.2 (24.8) | 64.3 (26.9) | 67.5 (26.6) | 69.5 (27.2) |
Time perspective (8) | 59.2 (22) | 57.5 (21.8) | 62.4 (24.5) | 66.6 (23.5) + |
Relapse (15) (n = 29) | 48.4 (24.4) | 50.6 (23) | 53.4 (24) | 55.7 (28.2) |
Modules | ||||
Coping (8) | 58.7 (19.1) | 58.1 (19.) | 59.6 (21) | 59.5 (20.6) |
Symptoms (20) | 54.6 (17.9) | 55.1 (18.6) | 59.5 (17.7) † | 63 (18.8) † |
Treatment (5) (n = 26) | 86.5 (15.7) | 78.6 (25) | 80.9 (18.1) | 88 (13.8) ¥ |